Association between cell growth and vancomycin resistance in clinical community-associated methicillin-resistant Staphylococcus aureus - Document - Gale Academic OneFile
PDF) VISA, hetero-VISA and VRSA: the end of the vancomycin era?
Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French h
xmlinkhub
KEGG PATHWAY: Nitrogen metabolism - Staphylococcus aureus subsp. aureus Mu3 (MRSA/hetero-VISA)
Acknowledgements References Genetic analysis of 17 genes in Staphylococcus aureus with reduced susceptibility to vancomycin (VIS
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis | Scientific Reports
Vancomycin-intermediate resistance in Staphylococcus aureus - ScienceDirect
14th March 2013 Susceptibility testing for Vancomycin in S. aureus : What do we do now? Robin A Howe Antimicrobial use in Primary Care. - ppt download
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis | Scientific Reports
Nucleotide sequence accession numbers Acknowledgements References Detection of TEM-52 in Salmonella enterica serovar Enteritidis
Hetero-intermediate Staphylococcus aureus
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis | Scientific Reports
Le cauchemar des bactéries multirésistantes
Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospital
Ceftaroline fosamil: drug profile and clinical data
Vancomycin-intermediate Staphylococcus aureus selected during vancomycin therapy of experimental endocarditis are not detected b
Frontiers | IS256-Mediated Overexpression of the WalKR Two-Component System Regulon Contributes to Reduced Vancomycin Susceptibility in a Staphylococcus aureus Clinical Isolate
Population analysis profile of VISA, hetero-VISA, and VSMRSA.... | Download Scientific Diagram
Lecture 4 Vancomycin resistance VRE VISA / hVISA / VRSA Thursday – 1/17/ ppt download
Impact of vancomycin use trend change due to the availability of alternative antibiotics on the prevalence of Staphylococcus aureus with reduced vancomycin susceptibility: a 14-year retrospective study | Antimicrobial Resistance & Infection
![PDF] Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/306a583084d23ac2766f122cd384bf9952effebb/4-Figure2-1.png "PDF] Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features. | Semantic Scholar")
PDF] Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features. | Semantic Scholar
Vancomycin-intermediate resistance in Staphylococcus aureus - ScienceDirect
Vancomycin-intermediate resistance in Staphylococcus aureus - ScienceDirect
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis | Scientific Reports
